The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Measles, Mumps and Rubella (MMR) Vaccines Market Research Report 2025
Synopsis
Measles can lead to otitis media, tracheitis, encephalitis and other complications.Mumps can cause hearing loss and inflammation of the ovaries or testes.German measles can lead to arthritis, encephalitis, conjunctivitis, miscarriage or birth defects.
The global Measles, Mumps and Rubella (MMR) Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Measles, Mumps and Rubella (MMR) Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measles, Mumps and Rubella (MMR) Vaccines.
Report Scope
The Measles, Mumps and Rubella (MMR) Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Measles, Mumps and Rubella (MMR) Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Measles, Mumps and Rubella (MMR) Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medlmmune
Johnson & Johnson
Merck
Sanofi
Serum
Bavarian Nordic
Astellas Pharma
Emergent BioSolutions
GlaxoSmithKline
Pfizer
CSL
Segment by Type
Monovalent Vaccine
Polyvalent Vaccine
Segment by Application
Immune Center
Vaccine Development Agencies and Organizations
Hospital
Laboratory
Biotechnology and Biopharmaceutical Companies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Measles, Mumps and Rubella (MMR) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Measles, Mumps and Rubella (MMR) Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Measles can lead to otitis media, tracheitis, encephalitis and other complications.Mumps can cause hearing loss and inflammation of the ovaries or testes.German measles can lead to arthritis, encephalitis, conjunctivitis, miscarriage or birth defects.
The global Measles, Mumps and Rubella (MMR) Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Measles, Mumps and Rubella (MMR) Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measles, Mumps and Rubella (MMR) Vaccines.
Report Scope
The Measles, Mumps and Rubella (MMR) Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Measles, Mumps and Rubella (MMR) Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Measles, Mumps and Rubella (MMR) Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medlmmune
Johnson & Johnson
Merck
Sanofi
Serum
Bavarian Nordic
Astellas Pharma
Emergent BioSolutions
GlaxoSmithKline
Pfizer
CSL
Segment by Type
Monovalent Vaccine
Polyvalent Vaccine
Segment by Application
Immune Center
Vaccine Development Agencies and Organizations
Hospital
Laboratory
Biotechnology and Biopharmaceutical Companies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Measles, Mumps and Rubella (MMR) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Measles, Mumps and Rubella (MMR) Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Measles, Mumps and Rubella (MMR) Vaccines Market Overview
1.1 Product Overview and Scope of Measles, Mumps and Rubella (MMR) Vaccines
1.2 Measles, Mumps and Rubella (MMR) Vaccines Segment by Type
1.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Monovalent Vaccine
1.2.3 Polyvalent Vaccine
1.3 Measles, Mumps and Rubella (MMR) Vaccines Segment by Application
1.3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Value by Application: (2024-2030)
1.3.2 Immune Center
1.3.3 Vaccine Development Agencies and Organizations
1.3.4 Hospital
1.3.5 Laboratory
1.3.6 Biotechnology and Biopharmaceutical Companies
1.4 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Estimates and Forecasts
1.4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue 2019-2030
1.4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Sales 2019-2030
1.4.3 Global Measles, Mumps and Rubella (MMR) Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Measles, Mumps and Rubella (MMR) Vaccines Market Competition by Manufacturers
2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Measles, Mumps and Rubella (MMR) Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Measles, Mumps and Rubella (MMR) Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Measles, Mumps and Rubella (MMR) Vaccines, Product Type & Application
2.7 Measles, Mumps and Rubella (MMR) Vaccines Market Competitive Situation and Trends
2.7.1 Measles, Mumps and Rubella (MMR) Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Measles, Mumps and Rubella (MMR) Vaccines Players Market Share by Revenue
2.7.3 Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Measles, Mumps and Rubella (MMR) Vaccines Retrospective Market Scenario by Region
3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Measles, Mumps and Rubella (MMR) Vaccines Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Region: 2019-2030
3.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Region: 2019-2024
3.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Region: 2025-2030
3.3 Global Measles, Mumps and Rubella (MMR) Vaccines Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region: 2019-2030
3.3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region: 2019-2024
3.3.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region: 2025-2030
3.4 North America Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country
3.4.1 North America Measles, Mumps and Rubella (MMR) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2019-2030)
3.4.3 North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country
3.5.1 Europe Measles, Mumps and Rubella (MMR) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2019-2030)
3.5.3 Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country
3.7.1 Latin America Measles, Mumps and Rubella (MMR) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2019-2030)
4.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2019-2024)
4.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2025-2030)
4.1.3 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2019-2030)
4.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2019-2024)
4.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2025-2030)
4.2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2019-2030)
5.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2019-2024)
5.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2025-2030)
5.1.3 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2019-2030)
5.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2019-2024)
5.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2025-2030)
5.2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medlmmune
6.1.1 Medlmmune Corporation Information
6.1.2 Medlmmune Description and Business Overview
6.1.3 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.1.5 Medlmmune Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Serum
6.5.1 Serum Corporation Information
6.5.2 Serum Description and Business Overview
6.5.3 Serum Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Serum Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.5.5 Serum Recent Developments/Updates
6.6 Bavarian Nordic
6.6.1 Bavarian Nordic Corporation Information
6.6.2 Bavarian Nordic Description and Business Overview
6.6.3 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.6.5 Bavarian Nordic Recent Developments/Updates
6.7 Astellas Pharma
6.6.1 Astellas Pharma Corporation Information
6.6.2 Astellas Pharma Description and Business Overview
6.6.3 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.7.5 Astellas Pharma Recent Developments/Updates
6.8 Emergent BioSolutions
6.8.1 Emergent BioSolutions Corporation Information
6.8.2 Emergent BioSolutions Description and Business Overview
6.8.3 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.8.5 Emergent BioSolutions Recent Developments/Updates
6.9 GlaxoSmithKline
6.9.1 GlaxoSmithKline Corporation Information
6.9.2 GlaxoSmithKline Description and Business Overview
6.9.3 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.9.5 GlaxoSmithKline Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Corporation Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
6.11 CSL
6.11.1 CSL Corporation Information
6.11.2 CSL Measles, Mumps and Rubella (MMR) Vaccines Description and Business Overview
6.11.3 CSL Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 CSL Measles, Mumps and Rubella (MMR) Vaccines Product Portfolio
6.11.5 CSL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Measles, Mumps and Rubella (MMR) Vaccines Industry Chain Analysis
7.2 Measles, Mumps and Rubella (MMR) Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Measles, Mumps and Rubella (MMR) Vaccines Production Mode & Process
7.4 Measles, Mumps and Rubella (MMR) Vaccines Sales and Marketing
7.4.1 Measles, Mumps and Rubella (MMR) Vaccines Sales Channels
7.4.2 Measles, Mumps and Rubella (MMR) Vaccines Distributors
7.5 Measles, Mumps and Rubella (MMR) Vaccines Customers
8 Measles, Mumps and Rubella (MMR) Vaccines Market Dynamics
8.1 Measles, Mumps and Rubella (MMR) Vaccines Industry Trends
8.2 Measles, Mumps and Rubella (MMR) Vaccines Market Drivers
8.3 Measles, Mumps and Rubella (MMR) Vaccines Market Challenges
8.4 Measles, Mumps and Rubella (MMR) Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Measles, Mumps and Rubella (MMR) Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Measles, Mumps and Rubella (MMR) Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Measles, Mumps and Rubella (MMR) Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) of Key Manufacturers (2019-2024)
Table 5. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Measles, Mumps and Rubella (MMR) Vaccines Average Price (USD/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Measles, Mumps and Rubella (MMR) Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Measles, Mumps and Rubella (MMR) Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Measles, Mumps and Rubella (MMR) Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Measles, Mumps and Rubella (MMR) Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Measles, Mumps and Rubella (MMR) Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measles, Mumps and Rubella (MMR) Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2019-2024) & (K Doses)
Table 18. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2025-2030) & (K Doses)
Table 20. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2019-2024) & (K Doses)
Table 27. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2025-2030) & (K Doses)
Table 28. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2019-2024) & (K Doses)
Table 32. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2025-2030) & (K Doses)
Table 33. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2019-2024) & (K Doses)
Table 37. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2025-2030) & (K Doses)
Table 38. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2019-2024) & (K Doses)
Table 42. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2025-2030) & (K Doses)
Table 43. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2019-2024) & (K Doses)
Table 47. Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2025-2030) & (K Doses)
Table 48. Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2019-2024)
Table 51. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2025-2030)
Table 52. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Type (2019-2024)
Table 59. Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Type (2025-2030)
Table 60. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Application (2019-2024)
Table 61. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Application (2025-2030)
Table 62. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Application (2019-2024)
Table 69. Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Application (2025-2030)
Table 70. Medlmmune Corporation Information
Table 71. Medlmmune Description and Business Overview
Table 72. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 73. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Product
Table 74. Medlmmune Recent Developments/Updates
Table 75. Johnson & Johnson Corporation Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 78. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 83. Merck Measles, Mumps and Rubella (MMR) Vaccines Product
Table 84. Merck Recent Developments/Updates
Table 85. Sanofi Corporation Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 88. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Product
Table 89. Sanofi Recent Developments/Updates
Table 90. Serum Corporation Information
Table 91. Serum Description and Business Overview
Table 92. Serum Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 93. Serum Measles, Mumps and Rubella (MMR) Vaccines Product
Table 94. Serum Recent Developments/Updates
Table 95. Bavarian Nordic Corporation Information
Table 96. Bavarian Nordic Description and Business Overview
Table 97. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 98. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Product
Table 99. Bavarian Nordic Recent Developments/Updates
Table 100. Astellas Pharma Corporation Information
Table 101. Astellas Pharma Description and Business Overview
Table 102. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 103. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Product
Table 104. Astellas Pharma Recent Developments/Updates
Table 105. Emergent BioSolutions Corporation Information
Table 106. Emergent BioSolutions Description and Business Overview
Table 107. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 108. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Product
Table 109. Emergent BioSolutions Recent Developments/Updates
Table 110. GlaxoSmithKline Corporation Information
Table 111. GlaxoSmithKline Description and Business Overview
Table 112. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 113. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Product
Table 114. GlaxoSmithKline Recent Developments/Updates
Table 115. Pfizer Corporation Information
Table 116. Pfizer Description and Business Overview
Table 117. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 118. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Product
Table 119. Pfizer Recent Developments/Updates
Table 120. CSL Corporation Information
Table 121. CSL Description and Business Overview
Table 122. CSL Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 123. CSL Measles, Mumps and Rubella (MMR) Vaccines Product
Table 124. CSL Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Measles, Mumps and Rubella (MMR) Vaccines Distributors List
Table 128. Measles, Mumps and Rubella (MMR) Vaccines Customers List
Table 129. Measles, Mumps and Rubella (MMR) Vaccines Market Trends
Table 130. Measles, Mumps and Rubella (MMR) Vaccines Market Drivers
Table 131. Measles, Mumps and Rubella (MMR) Vaccines Market Challenges
Table 132. Measles, Mumps and Rubella (MMR) Vaccines Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Measles, Mumps and Rubella (MMR) Vaccines
Figure 2. Global Measles, Mumps and Rubella (MMR) Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Type in 2023 & 2030
Figure 4. Monovalent Vaccine Product Picture
Figure 5. Polyvalent Vaccine Product Picture
Figure 6. Global Measles, Mumps and Rubella (MMR) Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Application in 2023 & 2030
Figure 8. Immune Center
Figure 9. Vaccine Development Agencies and Organizations
Figure 10. Hospital
Figure 11. Laboratory
Figure 12. Biotechnology and Biopharmaceutical Companies
Figure 13. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size (2019-2030) & (US$ Million)
Figure 15. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (2019-2030) & (K Doses)
Figure 16. Global Measles, Mumps and Rubella (MMR) Vaccines Average Price (USD/Dose) & (2019-2030)
Figure 17. Measles, Mumps and Rubella (MMR) Vaccines Report Years Considered
Figure 18. Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Manufacturers in 2023
Figure 19. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Measles, Mumps and Rubella (MMR) Vaccines Players: Market Share by Revenue in 2023
Figure 21. Measles, Mumps and Rubella (MMR) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2019-2030)
Figure 24. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2019-2030)
Figure 28. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2019-2030)
Figure 29. Germany Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2019-2030)
Figure 36. China Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2019-2030)
Figure 47. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Measles, Mumps and Rubella (MMR) Vaccines by Type (2019-2030)
Figure 57. Global Revenue Market Share of Measles, Mumps and Rubella (MMR) Vaccines by Type (2019-2030)
Figure 58. Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Type (2019-2030)
Figure 59. Global Sales Market Share of Measles, Mumps and Rubella (MMR) Vaccines by Application (2019-2030)
Figure 60. Global Revenue Market Share of Measles, Mumps and Rubella (MMR) Vaccines by Application (2019-2030)
Figure 61. Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Application (2019-2030)
Figure 62. Measles, Mumps and Rubella (MMR) Vaccines Value Chain
Figure 63. Measles, Mumps and Rubella (MMR) Vaccines Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
